document the benefit added by their services and that the field can grow and expand with the changing climate of health care. The National Society of Genetic Counselors ( www.nsgc.org ) has prioritized assessing and establishing outcome measures for genetic
Search Results
Time Studies of the Tasks Associated with Comprehensive Cancer Genetics Counseling
Brandie Heald and Charis Eng
QIM20-134: Genetic Testing for At-Risk Patients With Colorectal and/or Pancreatic Cancer at Our Institution, a Quality Improvement Project
Mina Shenouda, Vivek Yadala, Jennifer Dotson, and Toni Pacioles
is expected to cause about 45,750 deaths during 2019. The current NCCN Guidelines recommend genetic counseling and germline testing in all PC pts. This recommendation was based on evidence that germline genetic mutations were identified in 5.5% of all
QIM22-196: Participation in a Mentored Cancer Quality Improvement Collaborative Improves QI Aptitude Among Oncology Providers
Rachel Hae-Soo Joung, Brianna Marie D'Orazio, Jeana Springmann, Julie Johnson, Karl Y. Bilimoria, and Anthony D. Yang
-based genetic counseling referrals for breast cancer patients. An oncology-focused adaptation of the QI Knowledge Application Tool (QI-KAT), a validated QI assessment, was administered pre- and post-intervention. Three educators scored each de-identified exam
BPI20-014: Clinical Pathway and Education Implementation to Support Guideline Adherent Breast Cancer Care for Rural Women Under Age 50
Robin M. Lally, Elizabeth Reed, and Roksana Zak
Background: Adherence to National Comprehensive Cancer Network (NCCN) guidelines improves breast cancer therapy outcomes. While physician guideline adherence is often high, room for improvement exists. Shared surgical decision making, genetic
Casting a Wide Net While Building a Safety Net: Addressing Disparities in Genetic Testing for Hereditary Cancer
Julie Mak
genetic counselors, available in multiple languages. Genetic counseling assistants, trained and supported by our counselors, facilitate the process. Patients can elect to see a genetic counselor or may be referred for counseling based on their responses to
Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time
Filipa Lynce and Claudine Isaacs
results; the ability of the current model of genetic counseling practices to deal with the increase in patient volume; and the cost-effectiveness of such an approach. 8 , 9 One way of minimizing the identification of VUS, the impact of false
Your Genes: Getting the Best Fit
Margaret Tempero
reducing lifestyle risks that they can actually control? Considering the expanding need, the workforce shortage in genetic counseling is increasing to epic proportions, and I don't think there is a solution in sight. So I guess this is another call to
Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative
Julia R. Trosman, Christine B. Weldon, Michael P. Douglas, Allison W. Kurian, R. Kate Kelley, Patricia A. Deverka, and Kathryn A. Phillips
despite informed consent and genetic counseling, patients may not understand the immature state of evidence about numerous genes within panels (73%) and that their data are used for research, to which many would object if better informed. Payers' suspicion
A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer
Sean Dineen, Patrick M. Lynch, Miguel A. Rodriguez-Bigas, Sarah Bannon, Melissa Taggart, Colleen Reeves, Cathy Modaro, Michael Overman, George J. Chang, John M. Skibber, and Y. Nancy You
chemotherapy regimens. 20 However, in practice, adherence to this guideline is poor, 21 , 22 and many patients are not referred for genetic counseling and workup. 23 We hypothesized that system-based practice intervention, designed with the Six Sigma quality
Letter to the Editor: CHEK2 I157T - Pluto Among Numerous Low-Risk Genetic Factors Requiring Discharge From a Range of Pathogenic Variants?
Maxim Ivanov, Margarita Sharova, Andrea Olsen, Alexandra Lebedeva, Ekaterina Ignatova, Gerald Mouse, and Vladislav Mileyko
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic 1 provide substantial groundwork for specialist practice in diverse fields: medical oncology, genetic
